Fusion Outcomes of GLP-1 Agonist Therapy in Multilevel Cervical Spinal Fusion A Propensity-Matched Analysis

Keyphrases

• Receptor Agonist 100%
• Agonist Treatment 100%
• Glucagon-like 100%
• Cervical Spine Fusion 100%
• Fusion Outcomes 100%
• Propensity Analysis 100%
• 1 Receptor 100%
• Pseudarthrosis 38%
• Cervical Spine Surgery 11%
• Body Mass Index 5%
• Obesity Prevalence 5%
• Bone Metabolism 5%
• Low Incidence 5%
• Bone Resorption 5%
• Retrospective Analysis 5%
• Statistical Significance 5%
• Beneficial Effects 5%
• Hemoglobin A1c (HbA1c) 5%
• Pharmacodynamics 5%
• Fisher's Exact Test 5%
• Sex-dependent 5%
• Nicotine Dependence 5%
• Bone Formation 5%
• Diabetes Prevalence 5%
• CPT Codes 5%
• Osteoblastic Activity 5%
• Network Database 5%
• Osteoclastic Activity 5%
• TriNetX 5%
• Liraglutide 5%
• Propensity Matching 5%
• Pramlintide 5%
• Diamond Network 5%
• Tirzepatide 5%
• Semaglutide 5%
• Diagnosis Codes 5%
• Diabetes Mellitus 5%

Medicine and Dentistry

• Spinal Fusion 100%
• Glucagon-Like Peptide-1 Agonist 100%
• Pseudarthrosis 38%
• Spine Surgery 11%
• Prevalence 5%
• Diabetes Mellitus 5%
• Body Mass Index 5%
• Hemoglobins 5%
• Osteolysis 5%
• Tobacco Dependence 5%
• Bone Development 5%
• Ossification 5%
• Fisher Exact Test 5%
• Diagnosis Code 5%
• Cervical Spine 5%
• Pharmacodynamics 5%
• Current Procedural Terminology 5%
• Semaglutide 5%
• Liraglutide 5%
• Bone Remodeling 5%
• Tirzepatide 5%
• Pramlintide 5%